Fuat Demirelli
- Co-authors
- Mustafa ÖzgüroğluEvin BüyükünalSüheyla SerdengeçtiNil Molinas MandelGökhan DemirFatih SelçukbırıcıkSibel ErdamarAhmet Bılıcı
- Topics
- Gastric Cancer Management and Outcomes (6 papers)Colorectal Cancer Treatments and Studies (6 papers)Melanoma and MAPK Pathways (3 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBMC Cancer
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Fuat Demirelli
31 papers receiving 285 citations
Peers
Comparison fields: 5 of 58
- Oncology 135
- Pulmonary and Respiratory Medicine 97
- Pathology and Forensic Medicine 83
- Surgery 58
- Cancer Research 46
Countries citing papers authored by Fuat Demirelli
This map shows the geographic impact of Fuat Demirelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuat Demirelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuat Demirelli more than expected).
Fields of papers citing papers by Fuat Demirelli
This network shows the impact of papers produced by Fuat Demirelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuat Demirelli. The network helps show where Fuat Demirelli may publish in the future.
Co-authorship network of co-authors of Fuat Demirelli
This figure shows the co-authorship network connecting the top 25 collaborators of Fuat Demirelli. A scholar is included among the top collaborators of Fuat Demirelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuat Demirelli. Fuat Demirelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 5 | |
| 8 | 13 | |
| 9 | 2 | |
| 10 | 11 | |
| 11 | 1 | |
| 12 | 6 | |
| 13 | 8 | |
| 14 | 22 | |
| 15 | 25 | |
| 16 | Immunomodulating therapy with rIL-2 and interferon alpha-induces in vivo expression of Bcl-2, Fas (APO-1/CD95), and Fas ligand on peripheral lymphocytes (a pilot study). | 4 |
| 17 | 21 | |
| 18 | 6 | |
| 19 | 28 | |
| 20 | 7 |
About Fuat Demirelli
Fuat Demirelli is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 296 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Oncology (135 citations), Pathology and Forensic Medicine (83 citations) and Otorhinolaryngology (18 citations). Fuat Demirelli has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Mustafa Özgüroğlu, Evin Büyükünal, Süheyla Serdengeçti, Nil Molinas Mandel, Gökhan Demir, Fatih Selçukbırıcık, Sibel Erdamar, Ahmet Bılıcı, Deniz Tural and Gökhan Demir. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.